Cell and gene therapies hold the potential to cure the incurable – but the journey from hope to reality is far from simple. Our new eBook, Cell and Gene Therapy: Hope, Hype and Political Upheaval, brings together expert perspectives on the science, politics, and technology shaping this fast-evolving field.
Industry leaders share how next-generation CAR-Ts, automation, and synthetic DNA are transforming access and manufacturing – while political and funding uncertainty threaten to slow momentum in research.
You’ll also find insights on process intensification, regulatory strategy, and the partnerships driving progress from R&D to GMP. In addition, Leucid Bio’s John Maher reflects on his career from Michel Sadelain’s lab to developing CAR-T therapies for solid tumors.